Life Science/
Disease panels
Sequencing of disease Panels with MiSeq or NextSeq 2000
StarSEQ offers a wide range of different disease panels based on Illumina™ or Agilent™ technology. We offer complete services starting from DNA or RNA extraction from different types of tissues. The following panels are available:
- TruSight Oncology 500
- TruSight Tumor 170
- TruSight Hereditary Cancer Panel
- TruSight Cardio
- TruSight RNA Pan-Cancer panel
- TruSight Cancer
- ClearSeq Comprehensive Cancer
- ClearSeq Human DNA Kinome
- ClearSeq Human RNA Kinome
- ClearSeq Inherited Disease
- Clinical Research Exome
All Panels are For Research Use Only, Not for Use in Diagnostic Procedures.
TruSight Myeloid Sequencing Panel, the panel content was designed by a consortium of recognized experts in blood cancer disorders and targets genes frequently mutated in:
- Acute myeloid leukemia (AML)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms (MPN)
- Chronic myelogenous leukemia (CML)
- Chronic myelomonocytic leukemia (CMML)
- Juvenile myelomonocytic leukemia (JMML)
TruSight Tumor 170, a next-generation sequencing assay designed to cover 170 genes associated with common solid tumors, is an enrichment-based targeted panel that simultaneously analyzes DNA and RNA, covering a wide range of genes and variant types. The comprehensive nature provides laboratories with a deep view into the genetics of cancer.